529 related articles for article (PubMed ID: 21379341)
1. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor.
Perry ST; Buck MD; Lada SM; Schindler C; Shresta S
PLoS Pathog; 2011 Feb; 7(2):e1001297. PubMed ID: 21379341
[TBL] [Abstract][Full Text] [Related]
2. The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus.
Chen HW; King K; Tu J; Sanchez M; Luster AD; Shresta S
J Immunol; 2013 Oct; 191(8):4194-201. PubMed ID: 24043884
[TBL] [Abstract][Full Text] [Related]
3. Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies.
Ning YJ; Feng K; Min YQ; Cao WC; Wang M; Deng F; Hu Z; Wang H
J Virol; 2015 Apr; 89(8):4227-36. PubMed ID: 25631085
[TBL] [Abstract][Full Text] [Related]
4. Dengue Virus Control of Type I IFN Responses: A History of Manipulation and Control.
Castillo Ramirez JA; Urcuqui-Inchima S
J Interferon Cytokine Res; 2015 Jun; 35(6):421-30. PubMed ID: 25629430
[TBL] [Abstract][Full Text] [Related]
5. Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs.
Abdul-Sater AA; Majoros A; Plumlee CR; Perry S; Gu AD; Lee C; Shresta S; Decker T; Schindler C
J Immunol; 2015 Jul; 195(1):210-216. PubMed ID: 26019270
[TBL] [Abstract][Full Text] [Related]
6. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K
J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106
[TBL] [Abstract][Full Text] [Related]
7. Gamma interferon (IFN-γ) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-α/β receptor-deficient mice.
Prestwood TR; Morar MM; Zellweger RM; Miller R; May MM; Yauch LE; Lada SM; Shresta S
J Virol; 2012 Dec; 86(23):12561-70. PubMed ID: 22973027
[TBL] [Abstract][Full Text] [Related]
8. Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9.
Li W; Hofer MJ; Songkhunawej P; Jung SR; Hancock D; Denyer G; Campbell IL
J Biol Chem; 2017 Apr; 292(14):5845-5859. PubMed ID: 28213522
[TBL] [Abstract][Full Text] [Related]
9. Structural modeling and analysis of dengue-mediated inhibition of interferon signaling pathway.
Aslam B; Ahmad J; Ali A; Paracha RZ; Tareen SH; Khusro S; Ahmad T; Muhammad SA; Niazi U; Azevedo V
Genet Mol Res; 2015 Apr; 14(2):4215-37. PubMed ID: 25966194
[TBL] [Abstract][Full Text] [Related]
10. IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.
Li W; Hofer MJ; Jung SR; Lim SL; Campbell IL
J Virol; 2014 Jul; 88(13):7578-88. PubMed ID: 24760883
[TBL] [Abstract][Full Text] [Related]
11. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus.
Hofer MJ; Li W; Manders P; Terry R; Lim SL; King NJ; Campbell IL
J Virol; 2012 Jun; 86(12):6932-46. PubMed ID: 22496215
[TBL] [Abstract][Full Text] [Related]
12. An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses.
Carlin AF; Plummer EM; Vizcarra EA; Sheets N; Joo Y; Tang W; Day J; Greenbaum J; Glass CK; Diamond MS; Shresta S
Cell Rep; 2017 Nov; 21(6):1600-1612. PubMed ID: 29117564
[TBL] [Abstract][Full Text] [Related]
13. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
[TBL] [Abstract][Full Text] [Related]
14. Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model.
Sarathy VV; Infante E; Li L; Campbell GA; Wang T; Paessler S; Robert Beatty P; Harris E; Milligan GN; Bourne N; Barrett ADT
J Gen Virol; 2015 Oct; 96(10):3035-3048. PubMed ID: 26296350
[TBL] [Abstract][Full Text] [Related]
15. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
[TBL] [Abstract][Full Text] [Related]
16. Species-Specific Pathogenicity of Severe Fever with Thrombocytopenia Syndrome Virus Is Determined by Anti-STAT2 Activity of NSs.
Yoshikawa R; Sakabe S; Urata S; Yasuda J
J Virol; 2019 May; 93(10):. PubMed ID: 30814285
[TBL] [Abstract][Full Text] [Related]
17. Porcine reproductive and respiratory syndrome virus inhibits type I interferon signaling by blocking STAT1/STAT2 nuclear translocation.
Patel D; Nan Y; Shen M; Ritthipichai K; Zhu X; Zhang YJ
J Virol; 2010 Nov; 84(21):11045-55. PubMed ID: 20739522
[TBL] [Abstract][Full Text] [Related]
18. Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling.
Jia D; Rahbar R; Chan RW; Lee SM; Chan MC; Wang BX; Baker DP; Sun B; Peiris JS; Nicholls JM; Fish EN
PLoS One; 2010 Nov; 5(11):e13927. PubMed ID: 21085662
[TBL] [Abstract][Full Text] [Related]
19. Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue.
Upasani V; Scagnolari C; Frasca F; Smith N; Bondet V; Vanderlinden A; Lay S; Auerswald H; Heng S; Laurent D; Ly S; Duong V; Antonelli G; Dussart P; Duffy D; Cantaert T
Front Immunol; 2020; 11():605087. PubMed ID: 33391269
[TBL] [Abstract][Full Text] [Related]
20. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice.
Shresta S; Sharar KL; Prigozhin DM; Snider HM; Beatty PR; Harris E
J Immunol; 2005 Sep; 175(6):3946-54. PubMed ID: 16148142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
